✦ LIBER ✦

Follicular and endometrial immune profile of patients with severe ovarian insufficiency

✍ Scribed by Ledee, N.; Dubanchet, S.; Rahmati, M.; Balet, R.; Bensussan, A.; Chaouat, G.

Book ID: 123357507
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 46 KB
Volume: 100
Category: Article
ISSN: 1556-5653
DOI: 10.1016/j.fertnstert.2013.07.876

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Follicular-phase ovarian follicular flui

Follicular-phase ovarian follicular fluid and plasma cytokine profiling of natural cycle in vitro fertilization patients

✍ Baskind, N. Ellissa; Orsi, Nicolas M.; Sharma, Vinay 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 834 KB

Expression profile of immune response ge

Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome

✍ Renji Reghunathan; Manikandan Jayapal; Li-Yang Hsu; Hiok-Hee Chng; Dessmon Tai; 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 437 KB

A case series of patients with endometri

A case series of patients with endometrial insufficiency treated with pentoxifylline and alpha-tocopherol

✍ A.A. Okusami; M.E. Moore; J.M. Hurwitz; S.S. Richlin; M.P. Leondires 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Immunohistochemical profile of ovarian i

Immunohistochemical profile of ovarian inclusion cysts in patients with and without ovarian carcinoma

✍ Mittal, KhushR. ;Goswami, Sunanda ;Demopoulos, RitaI. 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 378 KB

The human ovarian follicular fluid level

The human ovarian follicular fluid level of interleukin-8 is associated with follicular size and patient age

✍ Beth A. Malizia; Yoo Sang Wook; Alan S. Penzias; Anny Usheva 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Pharmacokinetic profile and tolerability

Pharmacokinetic profile and tolerability of pimobendan in patients with terminal renal insufficiency

✍ M. Przechera; W. Roth; V. Kühlkamp; T. Risler; M. Haehl 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 450 KB

The pharmacokinetics of an i.v. bolus of pimobendan (P) 2.5 mg and 5.0 mg, its tolerability and the effect on heart rate and blood pressure have been studied in 12 subjects (42-70 y) suffering from severe terminal renal impairment. Plasma level data were compared with those obtained in a previous in